Challenges for New Alzheimer’s Drugs

Created using ChatSlide

This lecture provides an overview of Alzheimer's drugs with a focus on emerging treatments like Donanemab, emphasising its significance in Australia. It addresses the logistical challenges, such as the need for frequent IV infusions and specialist scarcity, alongside the financial barriers, including high costs and equity concerns due to the lack of PBS support. Additionally, the lecture highlights the regional infrastructure issues faced by areas with limited healthcare facilities and an...